Pathways to Exit: What We Learned at the 2026 MedTech Roadshow
What does it really take to build a medtech company that gets acquired, adopted and valued? Our 2026 MedTech Roadshow brought together founders, investors and industry leaders to explore the decisions that shape a company’s future long before exit — from regulatory and clinical strategy to commercialization, manufacturing and the real drivers of market adoption. With two stops on our 2026 tour: Houston,…